1ST ASIA PACIFIC CONFERENCE ON AIDS & CO-INFECTIONS TRANSLATING SCIENCE INTO CLINICAL PRACTICE
HONG KONG • 17 - 19 MAY 2016
EVALUATION REPORT
www.virology-education.com www.virology-education.com EXECUTIVE SUMMARY
The first Asia Pacific AIDS and Co-infections Conference (APACC) was organized on 17-19 May 2016 in Hong Kong. It attracted over 450 participants from 33 countries. This high profile conference brought together all stakeholders from the Asia Pacific region to share research results, important clinical developments and updates on ongoing and new trials in the field of HIV and co-infections. The program featured plenary sessions, symposia, oral abstract presentations and poster viewing sessions; thus providing a unique opportunity to meet colleagues in a scientific focused setting. Special attention was given to the empowerment of young investigators in this region who received a free registration upon acceptance of their abstract and could apply for a travel grant.
INTENT TO CHANGE
The conference was very well received which is reflected by the evaluation results. 92% of the respondents indicated that the lectures given in this conference have increased their knowledge, 75% agreed that the program is beneficial for the clinical management of their patients, 78% reported that they intend to incorporate the new information into the care of their patients.
PROGRAM
The program included 23 invited lectures, 27 oral abstract presentations, regular poster viewing sessions - and a panel discussion. Ample time was allocated for discussion. The evaluation scores of the presentations can be found on pages 16 - 25.
ABSTRACTS
The Organizing Committee received 200 abstracts, among them 27 were accepted for the oral presentations and 106 for the poster presentations.
The respondents confirmed that the scientific content of the abstracts was (highly) relevant to their work (average: 71%) and that the topics were (very) interesting (average: 84%).
FUTURE The majority of the respondents very much appreciated the conference to such an extent that they would recommend the meeting to their colleagues (90%) and plan to attend the 2017 meeting (92%).
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 3 “Excellent, I will recommend this conference to friends and colleagues to attend the 2nd meeting in the future.”
“Right place to update your knowledge on AIDS & co-infections with experience from Asian Region.” CONTENT
Executive Summary...... 3
Conference Description...... 6
Meeting Demographics...... 8
Acknowledgements...... 9
Program Committee (2016)...... 11
Scientific Committee ...... 12
Participants’ Feedback...... 16 Invited lectures, abstract-driven presentations ...... 16 Industry-supported symposia...... 23 Intent to change...... 24 Conference organization...... 24 General conference experience...... 25
Meeting Metrics...... 27
Conclusion...... 28
List of Registrants...... 29
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 5 CONFERENCE DESCRIPTION
BACKGROUND
Over the years, treating viral diseases has become more and more complex. Given the increase in therapeutic options in Asia and the Pacific, clinicians and researchers will clearly benefit from the opportunity to be informed and to discuss the newest data and their implications for clinical practice.
The APACC provides a much needed scientific platform that focuses on the developments, issues and needs in the Asia Pacific region. Researchers will have the opportunity to present and discuss the latest developments and will offered opportunities for interaction, networking and building collaborations. Top experts will integrate science and clinical practice through state-of-the-art lectures, clinical case discussions, round-table discussions and debates in order to reach consensus on best practices and develop guidelines for treatment.
The mission of the APACC is to provide a state-of-the-art forum for scientific interchange, medical education, community building and guidelines development for healthcare professionals in the Asia-Pacific region. Ultimately, the APACC conference aims at fostering knowledge sharing and capacity building in order to empower the HIV medical community and contribute to improvement of access to care in this region.
MEETING OBJECTIVES The objectives of this meeting are: • To bring together all stakeholders involved in treatment and prevention of HIV & Co-infections in Asia • To stimulate scientific interchange on ongoing and new research programs • To encourage in-depth discussion on challenging topics • To provide updates from other major international meetings • To translate novel findings into clinical practice • To educate healthcare professionals on optimal treatment and prevention strategies • To facilitate capacity building opportunities for young professionals • To create awareness of social and political challenges • To facilitate networking and stimulate collaborations • To reach consensus on best practices and develop guidelines for treatment
FORMAT
This 3 days regional meeting cconsists of invited lectures, round-table discussions, symposia, oral abstract- and poster presentations. In order to ascertain an interactive workshop setting, much time is allocated to discussion. As the meeting is abstract driven, it is an excellent platform for young investigators to present their research. To ensure the quality of the accepted abstracts, all submitted abstracts go through a blind, peer-reviewed proces conducted by the members of the Organizing and Scientific Committees.
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 6 CONFERENCE DESCRIPTION
UNIQUE MEETING FEATURES • A program with special focus on the needs in Asia and the Pacific; • A true scientific platform for the regional clinicians and clinical researchers to present their data; • To gain insight into important clinical developments and updates on ongoing and new trials in the field; • Featuring capacity building workshops and career development session for young professionals; • A great opportunity to network with your colleagues throughout Asia.
TARGET AUDIENCE
The target audience of this meeting consists of medical professionals involved in daily care of individuals infected with HIV and HIV-HCV, HIV-HBV, HIV-TB and other HIV co-infections, clinical, translational and basic researchers, physicians, general practitioners, nurses, residents, post-graduates and PhD students, government agency personnel, NGO representatives, health authority personnel, industry representatives, social workers, advocates and community workers and other healthcare professionals involved in treating HIV and co-infected patients.
LEARNING OBJECTIVES
• Participants will have thorough knowledge of the latest developments regarding treatment strategies for HIV and co-infected patients;
• Participants will be able to integrate the best practice based on the available resources in the region into daily clinical care to improve the quality of life of HIV and co-infected individuals.
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 7 MEETING DEMOGRAPHICS
NUMBER OF REGISTRATIONS
This year’s edition was attended by 471 participants from 33 countries.
GEOGRAPHICAL DISTRIBUTION OF REGISTRANTS
Australia 21 India 31 Pakistan 7 Taiwan 35
Austria 1 Indonesia 28 Philippines 4 Thailand 44
Bhutan 1 Israel 1 Papua New Guinea 2 The Netherlands 3
Cambodia 17 Japan 18 Singapore 13 United Kingdom 9
Cameroon 1 Laos 2 South Africa 1 USA 14
China 58 Malaysia 9 South Korea 8 Vietnam 29
France 1 Myanmar 6 Spain 1
Germany 2 Nepal 4 Sri Lanka 1
Hong Kong 97 New Zealand 1 Sweden 1
PROFESSIONAL BACKGROUND
56% of the respondents work mainly as a medical doctor, 16% are researchers, 11% are nurses and 12% “other”. 86% of the respondents are involved in daily care of HIV, followed by Hepatitis C (7%), Other (5%) and Hepatitis B (2%).
Occupation Area of expertise: Other Patient/ Community Hep C 5% Representative Hep B 7% 2% Other 2% Medical Student 12% 2% Nurse 11% Medical Doctor HIV Pharmacologist Researcher 56% 1% (Virologist) 86% 16%
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 8 ACKNOWLEDGEMENTS
The organizer acknowledges the following partners’ support that have made the 1st Asia Pacific AIDS & Co-infections Conference possible:
REGIONAL NETWORK Supporting the HIV, Viral Hepatitis and Sexual Health Workforce in the Asia Paci c.
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 9 ACKNOWLEDGEMENTS
The organizer acknowledges the contributions given by the following corporate supporters that have made the 1st Asia Pacific AIDS & Co-infections Conference possible:
TITANIUM LEVEL
GOLD LEVEL
SUPPORTER
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 10 PROGRAM COMMITTEE (2016)
JINTANAT ANANWORANICH, CHARLES BOUCHER, MD, PHD MD, PHD Erasmus Medical Center US Military HIV Research Rotterdam, The Netherlands Program MHRP, USA
MARK BOYD, MD, FRACP DAVID COOPER, MD, DSC
Kirby Institute, University of Kirby Institute, University of New South Wales, Australia New South Wales, Australia
CHING-LUNG LAI, MD, FRCP, SHARON LEWIN, FRACP, PHD, FRACP, FHKCP, FHKAM (MED) FAAHMS
University of Hong Kong, University of Melbourne, Hong Kong Australia
PATRICK CHUNG-KI LI, MBBS, NICHOLAS PATON, MD, PRCP FHKCP, FHKAM, FRCP National University of Singapore, Hong Kong Sanatorium and Singapore Hospital, Hong Kong
NITTAYA PHANUPHAK, MD, PHD JURGEN ROCKSTROH, MD, PHD
Thai Red Cross AIDS Research University of Bonn, Germany Centre, Thailand
JONATHAN SCHAPIRO, MD ANNETTE SOHN, MD
Sheba Medical Centre, Israel TREAT Asia, amfAR, Thailand
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 11 17 - 19 May 2016, Hong Kong SCIENTIFIC COMMITTEE
ZHIWEI CHEN, PHD, DVM JUN YONG CHOI, MD, PHD
The University of Hong Kong, Severance Hospital, Yonsei Hong Kong University College of Medicine, South Korea
RINO A GANI, MD, PHD ISHWAR GILADA, MD, DDV, FCPS
University of Indonesia, AIDS Society of India, Indonesia India
YEE-TAK HUI, FHKAM, FRCP CHIEN-CHING HUNG, MD, PHD
Queen Elizabeth Hospital, National Taiwan University Hong Kong Hospital, Taiwan
AIKICHI IWAMOTO, MD, DMSCI ADEEBA KAMARULZAMAN, MBBS, FRACP Japan Agency for Medical Research and Development, University Malaya, Japan Malaysia
THANA KHAWCHAROENPORN, SAYE KHOO, MD, PHD MD, MSC University of Liverpool, Thammasat University, United Kingdom Thailand
N. KUMARASAMY, MD, PHD ETERNITY LABIO, MD
YRGCARE Medical Centre, Asian Hospital and Medical India Center, Philippines
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 12 17 - 19 May 2016, Hong Kong SCIENTIFIC COMMITTEE
NGUYEN THI LAN ANH, MD, PHD THUY LE, MD The Wellcome Trust Major National Institute of Hygiene Overseas Programme, Oxford and Epidemiology, University Clinical Research Unit, Vietnam Vietnam
CHRISTOPHER KWOK CHONG MAN-PO LEE, MBBS, LEE, MD MSC,FHKCP, FHKAM, FRCP
Hospital Sungai Buloh, Queen Elizabeth Hospital, Malaysia Hong Kong
NELSON LEE, MBBS, MD, FRCP, SENG GEE LIM, MBBS, FRACP, FHKCP, FHKAM FRCP, MD Prince of Wales Hospital, The Chinese Univesity of Hong Kong, National University of Hong Kong Singapore, Singapore
HSI-HSUN LIN, MD, PHD HONGZHOU LU, MD, PHD
E-Da Hospital, I-Shou University, Shanghai Public Health Clinical Taiwan Center, Fudan University, China
TUTI PARWATI MERATI, MD, PHD PRAPHAN PHANUPAK, MD, PHD
Udayana University, Sanglah The Thai Red Cross AIDS Hospital, Research Centre, Bali, Indonesia Thailand
SHINICHI OKA, MD, PHD KIAT RUXRUNGTHAM, MD
National Center for Global Chulalongkorn University, Health and Medicine, Thailand Japan
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 13 17 - 19 May 2016, Hong Kong SCIENTIFIC COMMITTEE
YIMING SHAO, MD, PHD THOMAS MAN-KIT SO, MBBS, FHKCP, FHKAM, MRCP, FRCP, National Center for AIDS/STD RCPS, DTM&H Control and Prevention, The Hong Kong Society for China Infectious Diseases, Hong Kong
SOMNUEK SUNGKANUPARPH, MD AKIFUMI TAKAORI-KONDO, MD, PHD Faculty of Medicine Ramathibodi Hospital, Mahidol University, Kyoto University, Thailand Japan
TAWESAK TANWANDEE, MD OWEN TSANG, MBCHB, MRCP, FHKCP, FHKAM, MTH, DTM&H, Siriraj Hospital, Mahidol MSC, LSHTM, FRCP University, Hospital Authority Infectious Thailand Disease Centre, Princess Margaret Hospital, Hong Kong
NGUYEN VAN KINH, MD RUDI WISAKSANA, MD, PHD
National Hospital of Tropical Padjadjaran University, Hasan Diseases, Sadikin General Hospital, Vietnam Indonesia
EVY YUNIHASTUTI, MD, PHD HUI ZHUANG, MD
Faculty of Medicine Universitas Peking University Health Indonesia, HIV Integrated Clinic Science Center, Cipto Mangunkusumo Hospital, China Indonesia
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 14 17 - 19 May 2016, Hong Kong “Great opportunity for learning and building network.”
“Great chance to update knowledge especially for Asian patients.” PARTICIPANTS’ FEEDBACK
INVITED LECTURES, ABSTRACT-DRIVEN PRESENTATIONS TUESDAY 17 MAY
Plenary session (1): Opening session N=116
Honorary lecture: Future (Strongly) Agree Neutral (Strongly) Disagree Challenges in treatment optimization for Asia Topic is interesting 96% 4% 0% David Cooper, MD, DSc, Content is relevant to my work 89% 11% 0% Australia
Towards an HIV Cure; under (Strongly) Agree Neutral (Strongly) Disagree standing the major barriers Sharon Lewin, FRACP, PhD, Topic is interesting 95% 5% 0% FAAHMS, Australia Content is relevant to my work 77% 21% 2%
Towards an HIV Cure; clinical (Strongly) Agree Neutral (Strongly) Disagree strategies and trials Jintanat Ananworanich, Topic is interesting 94% 6% 0% MD, PhD, US Military HIV Content is relevant to my work 88% 11% 1% Research Program MHRP, USA Parallel session (1A): HIV Drug Resistance N=46
HIV Drug Resistance (Strongly) Agree Neutral (Strongly) Disagree Shinichi Oka, MD, PhD, National Center for Global Topic is interesting 79% 19% 2% Health and Medicine, Japan Content is relevant to my work 83% 13% 4%
Abstract-driven presentations
An overview of drug resistance mutations (Strongly) Agree Neutral (Strongly) Disagree in HIV-1 pol gene (Hong Kong, 1994 – 2013) Sabrina To, O_01 Topic is interesting 83% 14% 3% Content is relevant to my work 73% 24% 3%
Transmitted drug resistance mutations (Strongly) Agree Neutral (Strongly) Disagree among antiretroviral-naÏve adult patients in northern Vietnam Topic is interesting 81% 19% 0% Vu Phuong Thao, O_02 Content is relevant to my work 67% 33% 0%
The impact of NRTI resistance on the (Strongly) Agree Neutral (Strongly) Disagree public health approach to PI-based second-line therapy in resource limited Topic is interesting 79% 18% 3% settings Content is relevant to my work 66% 31% 3% Thuy Le, O_03
Next Generation Sequencing for (Strongly) Agree Neutral (Strongly) Disagree Detection of Drug Resistance Mutations in HIV-1 Topic is interesting 61% 30% 9% Elian Rakhmanaliev, O_04 Content is relevant to my work 51% 40% 9%
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 16 PARTICIPANTS’ FEEDBACK
Parallel session (1B): Perinatal, pediatric, and adolescent HIV priorities N=42
Elimination of perinatal HIV: (Strongly) Agree Neutral (Strongly) Disagree the Role of Safer Conception Strategies Topic is interesting 96% 4% 0% Shannon Weber, MSW, USA Content is relevant to my work 87% 8% 5%
They are not kids anymore: (Strongly) Agree Neutral (Strongly) Disagree Standing at the crossroads of adolescent HIV Care Topic is interesting 100% 0% 0% Annette Sohn, MD, Thailand Content is relevant to my work 90% 8% 2%
Abstract-driven presentations
Psychosocial Determinants of Anxiety (Strongly) Agree Neutral (Strongly) Disagree and Depression among Children of HIV- infected Parents: a 3-year Longitudinal Topic is interesting 77% 21% 2% Study in Mainland China Content is relevant to my work 66% 28% 6% Meiqi Xin, O_06
Parallel session (1C): Opportunistic Infections N=25
Advances in the treatment of (Strongly) Agree Neutral (Strongly) Disagree Cryptococcal Meningitis Jeremy Day, MD, PhD, Topic is interesting 96% 4% 0% Vietnam Content is relevant to my work 88% 12% 0%
TB Clinical Management (Strongly) Agree Neutral (Strongly) Disagree Challenges Nicholas Paton, MD FRCP, Topic is interesting 84% 16% 0% Singapore Content is relevant to my work 84% 16% 0%
Abstract-driven presentations
Concurrent outbreaks of hepatitis A and (Strongly) Agree Neutral (Strongly) Disagree shigellosis among HIV-infected MSM in Taiwan, 2015-2016: the emerging threat of Topic is interesting 89% 11% 0% enteric coinfections Content is relevant to my work 74% 26% 0% Yi-Chun Lo, O_07
The Patterns of Primary Cotrimoxazole (Strongly) Agree Neutral (Strongly) Disagree Prophylaxis in Adult HIV Patients in HIV Integrated Clinic Cipto Topic is interesting 70% 30% 0% Mangunkusumo Hospital Jakarta in 2004- Content is relevant to my work 75% 20% 5% 2013 Kenayu Mastini, O_08
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 17 PARTICIPANTS’ FEEDBACK
WEDNESDAY 18 MAY
Plenary session (2): Epidemiology / HIV Transmission N=59
HIV surveillance – Are we (Strongly) Agree Neutral (Strongly) Disagree missing out on key populations? Topic is interesting 93% 7% 0% Ying-Ru Lo, WHO Western Content is relevant to my work 87% 13% 0% Pacific, Philippines Transmission networks (Strongly) Agree Neutral (Strongly) Disagree among MSM Shui-Shan Lee, MBBS, MD, Topic is interesting 93% 7% 0% The Chinese University of Content is relevant to my work 86% 12% 2% Hong Kong, Hong Kong
Parallel session (2A): Long-term Comorbidities N=33
Long-term comorbidities (Strongly) Agree Neutral (Strongly) Disagree Saye Khoo, University of Liverpool, United Kingdom Topic is interesting 82% 18% 0% Content is relevant to my work 85% 15% 0%
Clinical case presentation (Strongly) Agree Neutral (Strongly) Disagree Man-Po Lee, MBBS, MSc, FHKCP, FHKAM, FRCP, Topic is interesting 94% 6% 0% Queen Elizabeth Hospital, Content is relevant to my work 88% 9% 3% Hong Kong
Abstract-driven presentations
Hyperlipidaemia and its association with (Strongly) Agree Neutral (Strongly) Disagree CD4 recovery following antiretroviral therapy Topic is interesting 93% 7% 0% Denise Pui-Chung Chan, O_09 Content is relevant to my work 87% 13% 0%
HIV Associated Osteoporosis in (Strongly) Agree Neutral (Strongly) Disagree Singapore: Prevalence and Risk Factors Nicholas Chew, O_11 Topic is interesting 79% 21% 0% Content is relevant to my work 77% 19% 4%
Metabolic Syndrome among Malaysian (Strongly) Agree Neutral (Strongly) Disagree HIV-Infected Patients: Preliminary Results from the HIV & Ageing Cohort Topic is interesting 93% 7% 0% Sivaraj Naidu, O_11 Content is relevant to my work 85% 15% 0%
Aspartate Aminotransferase to Platelet (Strongly) Agree Neutral (Strongly) Disagree Ratio Index (APRI) is a Simple Test for Diagnosis Liver Cirrhosis in HIV Topic is interesting 89% 11% 0% Patients Content is relevant to my work 85% 15% 0% Ketut Mariadi, O_12
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 18 PARTICIPANTS’ FEEDBACK
Parallel session (2B): Hepatitis HIV Co-infection N=18
Clinical case presentation (Strongly) Agree Neutral (Strongly) Disagree Mark Nelson,MD, Chelsea and Westminster Hospital, Topic is interesting 100% 0% 0% United Kingdom Content is relevant to my work 88% 12% 0%
Abstract-driven presentations
Sofosbuvir and Ribavirin therapy for the (Strongly) Agree Neutral (Strongly) Disagree Treatment of HIV/HCV co-infected patients with HCV GT1-4 Infection: The PHOTON-1 Topic is interesting 100% 0% 0% and -2 Trials Content is relevant to my work 89% 0% 11% Jürgen Rockstroh, O_13/14
Liver Fibrosis and Fatty Liver in Asian (Strongly) Agree Neutral (Strongly) Disagree HIV-monoinfected Patients Chung Yan Grace Lui, 0_15 Topic is interesting 68% 21% 11% Content is relevant to my work 68% 16% 16%
Modelling treatment scale-up in Australia (Strongly) Agree Neutral (Strongly) Disagree to achieve global hepatitis C virus incidence and mortality elimination targets Topic is interesting 78% 17% 5% Joseph Doyle, 0_16 Content is relevant to my work 66% 22% 12%
Eliminating hepatitis C transmission by (Strongly) Agree Neutral (Strongly) Disagree enhancing care and treatment among HIV co-infected individuals: The co-EC Study Topic is interesting 87% 13% 0% Joseph Doyle, 0_17 Content is relevant to my work 81% 19% 0%
Parallel session (2C): HIV Vaccine Research N=21
Development of HIV Vaccine (Strongly) Agree Neutral (Strongly) Disagree Candidates for Prevention and Treatment Topic is interesting 100% 0% 0% Sandhya Vasan, MD, Armed Content is relevant to my work 70% 25% 5% Forces Research Institute of Medical Sciences (AFRIMS), Thailand
Immune responses among (Strongly) Agree Neutral (Strongly) Disagree participants with additional boosting of ALVAC/AIDSVAX Topic is interesting 80% 20% 0% vaccines after receving the RV Content is relevant to my work 48% 47% 5% 144 regimen (RV 305 & RV 306 studies) Punnee Pitisuttithum, Clinical Tropical Medicine, Mahidol University, Thailand
HIV prevention and cure (Strongly) Agree Neutral (Strongly) Disagree using a potent bi-specific bnAb Topic is interesting 89% 11% 0% Zhiwei Chen, PhD, DVM, AIDS Content is relevant to my work 67% 22% 11% Institute of University of Hong Kong, Hong Kong
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 19 PARTICIPANTS’ FEEDBACK
Using the HVTN model to (Strongly) Agree Neutral (Strongly) Disagree conduct HIV vaccine clinical trials Topic is interesting 89% 11% 0% Xia Jin, MD,PhD, Institut Content is relevant to my work 59% 35% 6% Pasteur of Shanghai, Chinese Academy of Sciences, China
Plenary session (3): Prevention N=63
Integrating PreP in (Strongly) Agree Neutral (Strongly) Disagree prevention Robert Grant, MD, MPH, Topic is interesting 95% 5% 0% University of California, USA Content is relevant to my work 91% 9% 0%
Parallel session (3A): Clinical Management N=25 Abstract-driven presentations
Sensitive Detection of Tenofovir- (Strongly) Agree Neutral (Strongly) Disagree induced Tubular Injury with Urinary ß-2 Microglobuline in Vietnam Topic is interesting 87% 13% 0% Daisuke Mizushima, 0_18 Content is relevant to my work 88% 12% 0%
Tenofovir-induced kidney tubular (Strongly) Agree Neutral (Strongly) Disagree dysfunction in HIV-infected patients in Hong Kong Topic is interesting 90% 10% 0% Pui Chung Denise Chan, 0_19 Content is relevant to my work 86% 14% 0%
Safety and efficacy of tenofovir (Strongly) Agree Neutral (Strongly) Disagree disoproxil fumarate plus emtricitabine for HIV pre-exposure prophylaxis in Topic is interesting 100% 0% 0% Thailand Content is relevant to my work 86% 14% 0% Donn Colby, 0_20
Treat-all strategy decreased HIV infection (Strongly) Agree Neutral (Strongly) Disagree but increased syphilis in a community- based MSM cohort in Ulaanbaatar in 2015 Topic is interesting 79% 16% 5% Misano Takano, 0_21 Content is relevant to my work 68% 21% 11%
Test and Treat strategy has high (Strongly) Agree Neutral (Strongly) Disagree potential to reduce HIV and syphilis infections in a prison setting Topic is interesting 53% 37% 10% Tippawan Suthikiri, 0_22 Content is relevant to my work 53% 37% 10%
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 20 PARTICIPANTS’ FEEDBACK
Parallel session (3B): HIV Testing & Counseling and Prevention Interventions in High Risk Populations N=34 Abstract-driven presentations
High rate of HIV seroconversion among (Strongly) Agree Neutral (Strongly) Disagree long-term repeat HIV testers at the Thai Red Cross Anonymous Clinic Topic is interesting 91% 6% 3% Nittaya Phanuphak, 0_23 Content is relevant to my work 87% 10% 3%
A randomized controlled trial promoting (Strongly) Agree Neutral (Strongly) Disagree HIV self-testing with online real-time counseling on increasing HIV testing Topic is interesting 82% 15% 3% rate among MSM in Hong Kong Content is relevant to my work 76% 21% 3% Zixin Wang, 0_24
Go Viral On-line: Social Media Strategy (Strongly) Agree Neutral (Strongly) Disagree in HIV Testing Behaviour in Hong Kong Norman Kwan, 0_25 Topic is interesting 75% 22% 3% Content is relevant to my work 68% 26% 6%
A randomized controlled trial evaluating (Strongly) Agree Neutral (Strongly) Disagree the efficacy of a brief social media intervention in reducing sexual risk Topic is interesting 77% 19% 4% behaviors among MSM in Beijing Content is relevant to my work 76% 20% 4% Rui She, 0_26
Acceptability study on HIV Self-Testing (Strongly) Agree Neutral (Strongly) Disagree among female entertainment workers, men who have sex with men, and Topic is interesting 92% 4% 4% transgender women in Cambodia: A Content is relevant to my work 74% 22% 4% Qualitative Analysis Khuondyla Pal, 0_27
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 21 PARTICIPANTS’ FEEDBACK
THURSDAY 19 MAY
Plenary session (4): Hepatitis Viruses N=80
Hepatitis B (Strongly) Agree Neutral (Strongly) Disagree Stephen Locarnin, BSc, PhD, MBBS, FRC, Topic is interesting 90% 8% 2% Victorian Infectious Content is relevant to my work 83% 13% 4% Diseases Reference Labs, Australia
Hepatitis C (Strongly) Agree Neutral (Strongly) Disagree Ching-Lung Lai, MD, FRCP, FRAP, FHKAM, FHKCP, Topic is interesting 93% 5% 2% University of Hong Kong, Content is relevant to my work 85% 13% 2% Hong Kong
Hepatitis - HIV Co-infection (Strongly) Agree Neutral (Strongly) Disagree Jürgen Rockstroh, MD, University of Bonn, Topic is interesting 91% 6% 3% Germany Content is relevant to my work 85% 10% 5%
Plenary session (5): Novel Therapeutic Approaches/Future Challenges N=78
Long Acting Antivirals for (Strongly) Agree Neutral (Strongly) Disagree Treatment and Preventio Martin Markowitz, MD, Topic is interesting 87% 13% 0% Aaron Diamond AIDS Content is relevant to my work 74% 22% 4% Research Center, USA
Innovative Clinical Models (Strongly) Agree Neutral (Strongly) Disagree Nittaya Phanuphak, MD, PhD, Thai Red Cross AIDS Topic is interesting 94% 4% 2% Research Centre, Thailand Content is relevant to my work 94% 4% 2%
Roundtable Discussion: Cascade of Care N=46
(Strongly) Agree Neutral (Strongly) Disagree
Topic is interesting 92% 4% 4%
Content is relevant to my work 87% 9% 4%
Poster Viewing N=99
(Strongly) Agree Neutral (Strongly) Disagree
The poster session was a valuable element in the 89% 10% 1% program
The combination of poster session and Lunch was well 84% 13% 3% programmed
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 22 PARTICIPANTS’ FEEDBACK
INDUSTRY-SUPPORTED SYMPOSIA
HIV Management: Now and in the future N=43 Virology Education-organized symposium with funding support from ViiV Healthcare
(Strongly) Agree Neutral (Strongly) Disagree
Topic is interesting 89% 9% 2%
Content is relevant to my work 84% 14% 2%
Leaving no one behind: Optimising management of HIV/HCV co-infection in Asia and Europe N=52 Gilead Sciences-supported symposium
(Strongly) Agree Neutral (Strongly) Disagree
Topic is interesting 94% 6% 0%
Content is relevant to my work 92% 8% 0%
Choosing the Optimal Treatment Strategy N=45 Virology Education-organized symposium, with funding support from ViiV Healthcare
(Strongly) Agree Neutral (Strongly) Disagree
Topic is interesting 91% 7% 2%
Content is relevant to my work 87% 11% 2%
HIV and Hepatitis C co-infected patients: Still a special population? N=42 AbbVie-supported symposium
(Strongly) Agree Neutral (Strongly) Disagree
Topic is interesting 86% 12% 2%
Content is relevant to my work 78% 17% 5%
Leaving nobody behind: What needs to be done in resource-limited settings to treat everyone with HIV? N=58 Janssen-supported symposium
(Strongly) Agree Neutral (Strongly) Disagree
Topic is interesting 88% 12% 0%
Content is relevant to my work 72% 28% 0%
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 23 PARTICIPANTS’ FEEDBACK
INTENT TO CHANGE
(Strongly) Agree Neutral (Strongly) Disagree The lectures given in this conference have increased my knowledge of HIV and Co- 91% 5% 4% infections. This program is beneficial for the clinical management of my patients. 82% 13% 5%
I intend to incorporate the new information into the care of my patients. 81% 13% 6%
Some of the following factors might prevent me from implementing the gained knowledge:
% My patient/client population might not be appropriate for the implementation.. 11% My current office and practice systems might not accommodate the changes.. 26% My patients/ client might have trouble complying with these changes/ strategies. 17% The medications/ procedures discussed might not be available for my patients/ clients.. 41% These changes might be too time consuming. 2% Other reason(s), please specify:. 5%
CONFERENCE ORGANIZATION
Excellent & Very Good Good Fair & Poor Content of electronic announcements 83% 17% 0% Frequency of electronic announcements 84% 14% 2% Information of conference website 84% 9% 7% Online registration process 80% 14% 6% Online abstract submission process 80% 16% 4% Meeting venue 88% 10% 2% Meeting room 100% 0% 0% Audiovisuals 88% 12% 0% Food & beverage 48% 38% 14% Onsite logistics 81% 13% 6% Service level of Conference Secretariat 86% 12% 2%
Participants’ remarks:
• Excellent organized workshop, expanded and updated our knowledge in current HIV & co-infections treatment.
• There were many excellent presentations that are relevant to our works.
• The management of the APACC is very good: venue, accommodations, beautiful scene.
• Very well organized.
• Very nice because there’s a praying room and halal food.
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 24 PARTICIPANTS’ FEEDBACK
GENERAL CONFERENCE EXPERIENCE
Excellent & Very Good Good Fair & Poor Overall event experience 87% 8% 5% Opportunity of networking 73% 20% 7% Content of the APACC conference 92% 3% 5% Time allocation for discussion 79% 13% 8% Time allocation per presentation 82% 11% 7% (Strongly) Agree Neutral (Strongly) Disagree No commercial bias (product selling) perceived 76% 19% 5% I would recommend this conference to my peers 90% 5% 5% Plan to attend this conference next year 92% 5% 3%
Participants’ remarks:
• Right place to update your knowledge on AIDS & Co-infections with experience from Asian Region.
• Great to share.
• Good, appreciated the topics and the time.
• Excellent, I will recommend this conference to friends and colleagues to attend the 2nd meeting in the future.
• Informative.
• Sharing the newest prevention, treatment and care.
• It’s very informative in terms of clinical management.
• Great chance to update knowledge especially for Asian patients.
• Very informative.
• Many specialist from Asia-Pacific countries were invited to provide updates of their countries.
• Excellent learning experience and provision of an opportunity to know the impact of HIV and Hepatitis in the Asia Pacific region.
• The stratifies implemented to reduce or prevent the disease burden.
• Excellent.
• Great experience.
• Good workshop to participate.
• It’s good to share and to learn. Got more knowledge related to the co-infections with HIV, HBV and HCV.
• Great opportunity for learning and building network.
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 25 “There were many excellent presentations that are relevant to our works.”
“I learnt a lot of new things from APACC and look forward to share the presentations with my organization.”
“Excellent organized workshop, expanded and updated our knowledge in current HIV & co-infections treatment.” MEETING METRICS
How did you become aware of this conference:
I was motivated to attend this meeting because of:
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 27 CONCLUSION
The Organizing Committee is pleased with the results of the first ASIA PACIFIC AIDS & CO-INFECTIONS CONFERENCE. Most of the participants were impressed by the quality of the scientific content and the time allocation for the discussions. The majority also reported that they were satisfied with the overall meeting logistical arrangements and agreed it was a well organized event. Both the evaluation results and the participants’ feedback proved the success and importance of this conference. The Organizing Committee and the Organizing Secretariat shall further discuss the development of the scientific program for the 2nd edition in 2017, scheduled to take place in Hong Kong from 1 to 3 June, 2017.
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 28 LIST OF REGISTRANTS
Last name, name Institute Country Abbas, Riaz ViiV Healthcare Hong Kong Agtifa, Primadani Sudirman Medical Center Indonesia Akhtar, Ajaz Life Foundation Pakistan Alexander, Glory AIDS Society of India India Ananworanich, Jintanat US Military HIV Research Program USA Ann, Hea-Won GlaxoSmithKlein South Korea Ann, Hea-Won GlaxoSmithKlein South Korea Areeparambil, Sudheer Asha Kirana Charitable Trust India Arkart, Wibhupach AbbVie Thailand Avila, Claudio Gilead Sciences United Kingdom Ayu Yuli Gayatri, Anak Agung Division of Tropical and Infectious Disease Indonesia Ayyaz, Zeeshan Amitiel Welfare Society Pakistan Azuma, Kentaro Ise Red Cross Hospital Japan Bai, Nan Abbvie Pharmaceutical China Bai, Jinsong The Third People's Hospital of Kunming China Bai, Jianyun Tianjin Centers for Disease Control and Prevention China Bansal, Ruby Pushpanjali Crosslay Hospital India Basile, Kerri Westmead Hospital Australia Bhargava, Mani ICFAI University Dehradun India Bhrushundi, Charusheela AIDS Society of India India Bhrushundi, Milind AIDS Society of India India Bhrushundi, Sharvary AIDS Society of India India Bin Subawi, Muhammad The Works Singapore Izwan Bin Sulaiman, Helmi Malaysian Society for HIV Medicine Malaysia Boucher, Charles Erasmus Medical Center The Netherlands Boyd, Mark The Kirby Institute for infection and immunity in society Australia Brown, Dannae ViiV Healthcare Australia Budhathoki, Shyam Sundar B P Koirala Institute of Health Sciences Nepal Buh, Amos Wung University of Buea / Faculty of Health Sciences Cameroon Busarawan, Sriwanthana National Institute of Health Thailand Chahyani, Wiwit Faculty of Medicine, University of Indonesia Indonesia Chaiwarith, Romanee Bristol-Myers Squibb Thailand Chamreun, Choub Sok KHANA Cambodia Chan, San Janssen Pharmaceutical Hong Kong Chan, Sabrina AIDS Concern Hong Kong Chan, Pui Chung Denise The Chinese University of Hong Kong Hong Kong Chan, Fung Yee Hong Kong Infection Control Nurses' Association Hong Kong Chan, Wai Leng Hong Kong Infection Control Nurses' Association Hong Kong Chan, Bonnie Hong Kong Tourism Board Hong Kong Chan, Sze Mun Princess Margaret Hospital Hong Kong Chan, Shan Queen Elizabeth Hospital Hong Kong
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 29 LIST OF REGISTRANTS
Chan, Shuk Ying Queen Elizabeth Hospital Hong Kong Chan, Sze Nga Queen Elizabeth Hospital Hong Kong Chan, Wai Hung Queen Elizabeth Hospital Hong Kong Chan, Alice Society For AIDS Care Hong Kong Chan, Kai Ming Tuen Mun Hospital Hong Kong Chang, Chung Yuan Hospital Sungai Buloh Malaysia Chang, Shu-Ying Taoyuan General Hospital,Ministry of Health and Welfare Taiwan Chau, Marco Heart to Heart Hong Kong Chee, Heng Lee AbbVie Malaysia Chen, Zhiwei AIDS Institute of University of Hong Kong Hong Kong Chen, Yaokai Chongqing Public Health Medical Center China Chen, Qian Jinan Infectious Diseases Hospital China Chen, Xiejie No.8 Hospital, Guangzhou China Chen, Siyuan ViiV Healthcare Hong Kong Chen, XiaoHong AIDS Medical Quality Control Center of Heilongjiang Province China Chen, Chi Ping Hong Kong Infection Control Nurses' Association Hong Kong Chen, Tun-Chieh Kaohsiung Municipal Ta-Tung Hospital Taiwan Chen, Nan-Yu Linkou Chang Gung Memorial Hospital Taiwan Chen, Guan-Jhou National Taiwan University Hospital Taiwan Cheng, Ka Lam Hong Kong Infection Control Nurses' Association Hong Kong Cheng, Lin Shenzhen 3rd People's Hospital China Cheng, Shu-Hsing Taoyuan General Hospital,Ministry of Health and Welfare Taiwan Cheruvallil, Gopalakrishnan, AIDS Society of India India Mini Chetchotisakd, Ploenchan Srinagarind Hospital Thailand Cheung, Ma Kee Society For AIDS Care Hong Kong Cheung, Ka Hin The Chinese University of Hong Kong Hong Kong Chew, Nicholas National University of Singapore Singapore Chhim, Kolab KHANA Cambodia Chhoun, Pheak KHANA Cambodia Chidgey, Andrew AIDS Concern Hong Kong Chiong, Justin University of Liverpool United Kingdom Choi, Esther Society For AIDS Care Hong Kong Chonpajalasopa, Alisa Bristol-Myers Squibb Thailand Choo, Martin Global Network of People Living with HIV Malaysia Chow, Hul Ming HKSID Hong Kong Chu, Kwok Pui University of Hong Kong Hong Kong Chuah, Stefanie AMICULUM (Singapore) Pte Ltd Singapore Chung, Wai Yee Queen Elizabeth Hospital China Colby, Donn Thai Red Cross AIDS Research Centre Thailand Cooper, David University of New South Wales Australia Crooks, Levinia Australasian Society for HIV Viral Hepatitis & Sexual Health Australia Medicine
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 30 LIST OF REGISTRANTS
Dai, Lili Beijing You An China Dang, Nathalie ViiV Healthcare France Day, Jeremy Hospital for Tropical Diseases Vietnam De Jesus, Loreta De La Salle University Medical Center Philippines Dian Sukmawati, Ni Made Division of Tropical and Infectious Disease Indonesia Dewi Ding, Haibo The First Hospital of China Medical University China Ding, Yi The 6th People's Hospital of Xinjiang China Djauzi, Samsuridjal Cipto Mangunkusumo General Hospital Indonesia Do, Hong Thanh Thi Out Patients Clinic Ho Chí Minh Citiy Vietnam Do Duy, Cuong Bach Mai Hospital Vietnam Dong, Ngo Thi Anh HCMC HIV/AIDS Association Vietnam Doyle, Joseph The Alfred Hospital Australia Eisler, Adrian ACON Australia Eksettakarn, Suriya Bristol-Myers Squibb Thailand Fan, Joanne Yuen Sze Abbvie Hong Kong Fan, Susan Yun-Sun Hong Kong Advisory Council on AIDS Hong Kong Fong, David coHealth Community Health Service Australia Francis, Clement Joy Kingsly Nestle India Limited India Francis, Delfin Lovelina Tamil Nadu Dr MGR Medical University India Fransiscus, Ginting RSUP H. Adam Malik Indonesia Fujiwara, Tamio Shionogi & Co., Ltd Japan Fumero, Emilio ViiV Healthcare Spain Gani, Rino University of Indonesia Indonesia Gilada, Ishwar AIDS Society of India India Grant, Robert UCSF - The J. David Gladstone Inst. USA Gunawan, Carta Agrawanto AW Syahranie Samarinda Hospital Indonesia Hadinoto, Daniel Faculty of Medicine, University of Indonesia Indonesia He, Shenghua Public Health Center of Chengdu China Hemal, Alok DR. Ram Manohar Lohia Hospital India Hirano, Atsushi National Hospital Organization Nagoya Medical Center Japan Ho, David Aaron Diamond AIDS Research Center USA Ho, Janet Lai Mei Abbvie Hong Kong Ho, Kai-man Princess Margaret Hospital Hong Kong Hoe, Kwun Hung AIDS Concern Foundation Hong Kong Hosuru Subramanya, Supram Manipal College of Medical Sciences Nepal Hou, Yen Ching Chris The Works Singapore Hourt, Maly KHANA Cambodia Hsu, Gwo-Jong Chiayi Christian Hospital Taiwan Huang, Claire ViiV Healthcare Hong Kong Huang, Chun Kai E-DA Hospital Taiwan Huang, Jeffrey Mong-Chieh GlaxoSmithKlein Taiwan Huang, Yi-Chia National Taiwan University Hospital Taiwan
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 31 LIST OF REGISTRANTS
Hui, Yee-Tak Queen Elizabeth Hospital Hong Kong Hung, Chien-Ching National Taiwan University Hospital Taiwan Hung, Than Manh National Hospital for Tropical Diseases Vietnam Huynh Thu, Thuy AbbVie BioPharmaceuticals Vietnam Hwang, Ta-Fen GSK Taiwan Taiwan Intalapaporn, Poj Rajvithi Hospital Thailand Ip, Eyre Chun Fa Abbvie Hong Kong Ischovitsch, Karl General Hospital Mistelbach Austria Iser, David The Alfred Hospital Australia Iskandar, Azwa University Malaya Medical Center Malaysia Ismanoe, Gatoet RS Syaiful Anwar Indonesia Iwamoto, Aikichi University of Tokyo Japan Jacob, Saramma Mini Tamilnadu Dr MGR Medical University India Jantarapakde, Jureeporn Thai Red Cross AIDS Research Centre Thailand Jiang, Tian Jun Beijing 302 Hospital China Jiang, tingting Zhejiang Provincial CDCP China Jianlin, Wu 1st Affiliated Hospital of Guangxi Medical University China Jin, Xia Chinese Academy of Sciences China Joradol, Rassamee AbbVie Thailand Katpattil, Sabin Yenepoya Dental College And Hospital India Katu, Sudirman RS Wahidin Sudiruhosodo Indonesia Kelly, Melissa Australasian Society for Infectious Diseases Australia Kessler, Harold ViiV Healthcare USA Khaiwkhaopho, Wannee Thai Red Cross Thailand Khan, Asif Iqbal Dow University of Health Sciences Pakistan Khoo, Saye University of Liverpool United Kingdom Khun, Rathana HACC Cambodia Cambodia Khy, Udom FHI360 Cambodia Kiertiburanakul, Sasisopin Ramathibodi Hospital Thailand Kim, SoHee Gilead Sciences Ltd South Korea Kim, Ki-Hyon GSK South Korea Kinai, Ei National Center for Global Health and Medicine Japan Ko, Wing-Man Food and Health Bureau, Hong Kong Hong Kong Ko, Li-chin Gilead Taiwan Ko, Nai-Ying National Cheng Kung University Hospital Taiwan Kok, Sze Ping Society For AIDS Care Hong Kong Koteff, Justin ViiV Healthcare USA Ku, Nomik AIDS concern Hong Kong Ku, Wen-Wei Taipei Veterans General Hospital Taiwan Kumarasamy, YRG Centre for AIDS Research and Education India Nagalingesawaran Kurimura, Naoko ViiV Healthcare Japan Kuwano, Yuki ViiV Healthcare Japan
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 32 LIST OF REGISTRANTS
Kwan, Norman AIDS Concern Hong Kong Kwan, Tsz Ho The Chinese University of Hong Kong Hong Kong Kwong, Tsz Shan Queen Elizabeth Hospital Hong Kong Kyaw, Sai Phone Clinical care HIV/AIDS Myanmar Country Lai, Ka Yi Society For AIDS Care Hong Kong Lai, Tung Shing Society For AIDS Care Hong Kong Lai, Ching-Lung Queen Mary Hospital, the University of Hong Kong Hong Kong Lai, Sin Man Selma Princess Margaret Hospital Hong Kong Lal, Dewa Pakshage Chula National Hospital of Sri lanka Sri Lanka Kanishka Ananda Lalthanmawia, Ronald Christian Medical Association of India India Lam, Veronica Gilead Sciences Hong Kong Lam, Wilson Queen Elizabeth Hospital Hong Kong Lan, Irene Gilead Sciences Hong Kong Limited Hong Kong Lau, Lai Yung Society For AIDS Care Hong Kong Lau, Alice Janssen Pharmaceutical Hong Kong Lau, Jason AIDS Concern Hong Kong Lau, Adeline Society For AIDS Care Hong Kong Lau, Josephine Society For AIDS Care Hong Kong Law, Irene Hong Kong Tourism Board Hong Kong Lay, Phirum Sihanouk Hospital Center of Hope Cambodia Le, Thuy Oxford University Clinical Research Unit Vietnam Lee, Nelson Prince of Wales Hospital Hong Kong Lee, Man Po Queen Elizabeth Hospital Hong Kong Lee, Shui-Shan The Chinese University of Hong Kong Hong Kong Lee, Kuan Yeh Gilead Sciences Taiwan Lee, Kum-Sook Health Chosun South Korea Lee, Chun Lun Gilead Sciences Hong Kong Lee, Hyun-ho Gyeonggi-do Institute of Health & Environment South Korea Lee, Susan Shin-Jung Kaohsiung Veterans General Hospital Taiwan Lee, Serina Society For AIDS Care Hong Kong Lee, Cheng Chaun Tan Tock Seng Hospital Singapore Leung, Wallace Fu On Abbvie Hong Kong Leung, Mandy Gilead Sciences Hong Kong Leung, Wai Shing Princess Margaret Hospital Hong Kong Leung, Tiffany Society For AIDS Care Hong Kong Lewin, Sharon Monash University Australia Li, Patrick Hong Kong Sanatorium & Hospital Hong Kong Li, Grace Gilead Sciences Inc. China Li, Linghua No.8 Hospital, Guangzhou China Li, Huan Chongqing Infectious Diseases Medical Center China Li, Jinghua The Chinese University of Hong Kong Hong Kong Lim, Seng-Gee National University of Singapore Singapore
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 33 LIST OF REGISTRANTS
Lim, Hoe Teong Henry Member HKASLD China Lin, Hsi-Hsun E-Da Hospital, I-Shou University Taiwan Lin, Hsi-Hsun E-Da Hospital Taiwan Lin, Tai Cheng Mylan Taiwan Lin, Ada Special Preventive Programme Hong Kong Lin, Kuan-Yin Taipei City Hospital, Kunming Prevention and Control Center Taiwan Liou, Bo-Huang Mackay Memorial Hospital Taiwan Liu, Jengting Abbvie Taiwan Taiwan Liu, Huanxia Public Health Center of Chengdu China Liu, Shuiqing Guiyang Public Health Clinical Center China Liu, Sky Mylan Taiwan Liu, Jun The Third People's Hospital of Kunming China Lo, Ying-Ru World Health Organization Philippines Lo, Yi-Chun Centers for Disease Control , R.O.C. Taiwan Locarnini, Stephen Victorian Infectious Diseases Reference Labs Australia Low, Lee Lee Malaysian Society for HIV Medicine Malaysia Lu, Hongzhou Shanghai Public Health Center China Lu, Min-Chi Chung Shan Medical University Hospital Taiwan Lu, Wei Peking Union Medical College Hospital China Lui, Chung Yan Grace The Chinese University of Hong Kong Hong Kong Luis, Hendry IDI Indonesia Luk, Hing Yin Society For AIDS Care Hong Kong Lung, Kwok Cheung Pamela Youde Nethersole Eastern Hospital Hong Kong Luo, Robert Roche Molecular Systems USA Ma, Ying Lai Society For AIDS Care Hong Kong Ma, Qiaoqin Zhejiang Provincial CDCP China Machiraju, Ramakrishna Cavidi AB Sweden Mahakkanukrauh, Bussakorn GSK Thailand Thailand Maharani, Kartika Faculty of Medicine, University of Indonesia Indonesia Mai, Thanh Binh Janssen Cilag Vietnam Manosuthi, Weerawat Bamrasnaradura Infectious Diseases Institute Thailand Maria, Suzy Indonesian Association of Physicians in AIDS Care Indonesia Mariadi, Ketut Udayana University Indonesia Markowitz, Martin Aaron Diamond AIDS Research Center USA Marriott, Debbie St Vincents Hospital Australia Mastini, Ken Ayu Faculty of Medicine, University of Indonesia Indonesia Maxwell, Celia Howard University Hospital USA McBride, George Merck Singapore McManus, Dane ViiV Healthcare Australia Mekprasan, Suwanna Chulalongkorn Hospital Thailand Melgar, Maria Isabel AIDS Society of the Philippines Philippines Meng, Zhihao Longtan Hospital in Guangxi Province China
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 34 LIST OF REGISTRANTS
Mertens, Michael Gilead Sciences Europe United Kingdom Mertenskoetter, Thomas T.O.M. Life Science Consulting Germany Michaels, Jessica National University Hospital Singapore Miller, David Pathos BioScience USA Ming, Shiu Kow Medicine Hong Kong Mini, Malathi AIDS Society of India India Mizushima, Daisuke National Center for Global Health and Medicine Japan Mohammed, Perry Johnson & Johnson United Kingdom Mootsikapun, Piroon Bristol-Myers Squibb Thailand Morea, Geita PSRH and PNG O&G Society Murphy, April Individual Australia Mynak, Mimi Lhamu Jigme Dorji Wangchuk National Referral Hospital Bhutan Nadee, Thanabordee The Thai Red Cross AIDS Research Center Thailand Naidu, Sivaraj University of Malaya Malaysia Nair, Aswathi AIDS Society of India Navanukroh, Oranich Bristol-Myers Squibb Thailand Neema, Negi All India Institute of Medical Sciences India Nelson, Mark Chelsea and Westminster Hospital United Kingdom Nelwan, Erni University of Indonesia Indonesia Ng, Sharon GSK Hong Kong Ng, Ringo Gilead Sciences Hong Kong Nguyen, Le Minh Trang Janssen Cilag Vietnam Nguyen, Ngoc Thoa Medicine center district 8 Vietnam Nguyen, Thi Hoai Dung National Hospital for Tropical Diseases Vietnam Nguyen Dinh Le, Hung Mai Khoi Volunteer OPC Vietnam Nguyen Huu, Hai, HIV/AIDS Global Fund Project, Ministry of Health Vietnam Nguyen Kim, Thu Hanoi Medical University Vietnam Nguyen Le Nhu, Tung National Hospital of Tropical Diseases Vietnam Nguyen Ngoc, Trinh HCMC HIV/AIDS Center Vietnam Nguyen Quoc, Tip AbbVie BioPharmaceuticals Vietnam Nguyen Thi, Lan Anh National Institute of Hygiene and Epidemiology Vietnam Nguyen Thi, Dung National Hospital for Tropical Diseases Vietnam Nguyen Thi Mai, Thu Hospital for Tropical Diseases Vietnam Nhung, Vo Thi Tuyet Health Advanced Initiative in Vietnam (HAIVN) Vietnam Nilsoge Guruswamy, Deepak Karnataka University India Niu, Mengyue AIDS Institute of University of Hong Kong Hong Kong Nonglux, Singhakowinta Bristol-Myers Squibb Thailand Nyein, Htun Lwin Research in HIV/AIDS HAEMATOLOGY Myanmar Country Ohashi, Eisei Janssen Pharmaceutical K.K Japan Ohira, Noriyuki Janssen Pharmaceutical K.K Japan Oka, Shinichi National Center for Global Health and Medicine Japan Ong, Pamela Gilead Sciences Singapore Singapore O'Rourke, Matthew HIV Outreach Team Australia
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 35 LIST OF REGISTRANTS
Oswal, Jitendra Bharati Vidyapeeth Medical College India Pal, Khuondyla KHANA Cambodia Pankam, Tippawan The Thai Red Cross AIDS Research Centre Thailand Park, Sangjun Medical Observer South Korea Parwati Merati, Tuti Udayana University Indonesia Patama, Suttha Bristol-Myers Squibb Thailand Paton, Nicholas National University of Singapore Singapore Pattanachaiwit, Supanit The Thai Red Cross AIDS Research Centre Thailand Pawadshettar, Shivakumar Kasturba Medical College India Peacock, Natasha Elements Communications United Kingdom Peng, Qiaoli Shenzhen 3rd People's Hospital China Perveen, Shadab Karachi Institute of Biotechnology and Genetic Engineering Pakistan Pham Kim, Dung HIV/AIDS Global Fund Project, Ministry of Health Vietnam Pham Thi Hai, Ly HCMC AIDS Center Vietnam Phanjaroen, Kannapat The Thai Red Cross AIDS Research Centre Thailand Phanuphak, Nittaya Thai Red Cross AIDS Research Centre Thailand Phanuphak, Praphan The Thai Red Cross AIDS Research Centre Thailand Phoummalinno, Ya Vientiane Youth Centre for Health and Development Laos Phoungchum, Puthita Chulalongkorn University Thailand Phyu, Sabai Clinical care HIV/AIDS Myanmar Country Pinili, Ryan AIDS Society of the Philippines Philippines Pitisuttithum, Punnee Mahidol University Thailand Pokhrel, Khem Narayan Integrated Development Foundation Nepal Polo, Espino Victorian AIDS Council Australia Poudel, Prakash B P Koirala Institute of Health Sciences Nepal Pramod, S Health Alert Organisation of India India Pullishery, Fawaz Educare Institute of Dental Sciences India Qin, Shanfang Longtan Hospital in Guangxi Province China Radhakrishnan, Sajithkumar AIDS Society of India India Radian, Achmad prison of sukabumi Indonesia Rahmah, Fatima Padjadjaran University, Faculty of Medicine Indonesia Rakhmanaliev, Elian Vela Research Singapore Pte. Ltd Singapore Rana, Jayesh Surat Municipal Institute Of Medical Education And Research India Rashid, Javed AbbVie Singapore Ratanasuwan, Winai Siriraj Hospital, Mahidol University Thailand Rayapu, Ramesh Babu BOSS&CIPCA (A CBO) India Reeves, Ally Ashfield Healthcare United Kingdom Rick, Franklin Auckland District Health Board New Zealand Rockstroh, Juergen University of Bonn Germany Roney, Janine HIV HCV coinfection Elimination Project Australia Ruffell, Carol Janssen Global Access Programmes, Virology South Africa Rumpf, Margaret GSK Hong Kong Ruxrungtham, Kiat Chulalongkorn Hospital Thailand
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 36 LIST OF REGISTRANTS
Saeed, Khan Dow University of Health Sciences Pakistan Saim, Jamil Ghazi Herbal Clinic For Liver Diseases Pakistan Sakabe, Shigetoshi Ise red Cross Hospital Japan Saw, Htin Aung Clinical care HIV/AIDS Myanmar Country Schapiro, Jonathan Sheba Medical Center Israel Sereywat, Peang HACC Cambodia Cambodia Sethaputra, Chuenkamol TREAT Asia/amfAR Thailand She, Rui The Chinese University of Hong Kong China Shen, Yinzhong Shanghai Public Health Center China Shih, Cindy GlaxoSmithKlein Taiwan Shu, Jiayi Institut Pasteur of Shanghai China Sin, Winnie Special Preventive Programme Hong Kong Sin Man, Au Queen Elizabeth Hospital Hong Kong Singh, Udaya Pratap Sam Higginbottom Institute of Agriculture, Technology & India Sciences Singtoroj, Thida TREAT Asia/amfAR Thailand Smith-Plenderleith, James Janssen Asia Pacific Hong Kong So, Thomas The Hong Kong Society for Infectious Diseases Hong Kong So, Kimhai KHANA Cambodia Soeung, Sunpisith Sihanouk Hospital Center of Hope Cambodia Sohn, Annette TREAT Asia/amfAR - The Foundation for AIDS Research Thailand Sopheak, Thai Sihanouk Hospital Center of Hope Cambodia Srey, Pichsovannary Sihanouk Hospital Center of Hope Cambodia Srila-or, Airin The Thai Red Cross AIDS Research Centre Thailand Steinhart, Corklin ViiV Healthcare USA Su, Ting-Yi Linkou Chang Gung Memorial Hospital Taiwan Sun, Yan Ming Beijing Centers for Diseases Control and Prevention China Sun, Yan No. 6 Hospital, Zhenzhou China Sun, Na-Le Taoyuan General Hospital,Ministry of Health and Welfare Taiwan Sun, Na-Li Taoyuan General Hospital,Ministry of Health and Welfare Taiwan Suparak, Supaporn National Institute of Health Thailand Susila Utama, I Made Division of Tropical and Infectious Disease Indonesia Takahashi, Masaaki National Hospital Organization Suzuka Hospital Japan Takano, Misao National Center for Global Health and Medicine Japan Takaori-Kondo, Akifumi Kyoto University Japan Tak-Yin Tsang, Owen Princess Margaret Hospital Hong Kong Tamaishi, Yuya Ise Red Cross Hospital Japan Tan, Nicole Gilead Sciences Singapore Singapore Tantipaibulvut, Somsri Thai Red Cross AIDS Research Centre Thailand Tantisiriwat, Woraphot Srinakharinwirot University Thailand Tawatchai, Apidechkul Mae Fah Luang University Thailand Thaigarajan, Parumasivam The University of Sydney Australia Thaithidaden, Um KHANA Cambodia
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 37 LIST OF REGISTRANTS
Thao, Vu Phuong Oxford Clinical Research Unit-Vietnam Vietnam Thida Soe, Theint Doctors without Borders Myanmar Country Thomas, Alexander AIDS Society of India India Thomas, Lisa Elements Communications United Kingdom Thomas Alexander, Deepak AIDS Society of India India Thongpaen, Suchart Bristol-Myers Squibb Thailand Tippawan, Sutthikiri Thai Red Cross AIDS Research Centre Thailand To, Sabrina University of Hong Kong Hong Kong Togami, Hiroaki National Hospital Organization Nagoya Medical Center Japan Tong, Qian The 6th People's Hospital of Xinjiang China Trachunthong, Deondara Thai Red Cross AIDS Research Centre Thailand Tran, Ly Agence Nationale de Recherche sur le Sida Vietnam Tran Quoc, Tuan No.09 Hospital Vietnam Truong Huu, Khanh Nhi Dong 1 Hospital Vietnam Tso, Eugene United Christian Hospital Hong Kong Tso, Eugene United Christian Hospital Hong Kong Tuot, Sovannary KHANA Cambodia Utomo, Muhammad Faisal Udayana University Indonesia Putro van Baar, Gilles Janssen Biologics BV The Netherlands van Delft, Yvon Janssen-Cilag B.V. The Netherlands Van Lunzen, Jan ViiV Healthcare USA van Wyk, Jean AbbVie USA Vasan, Sandhya Armed Forces Research Institute of Medical Sciences Thailand Vo Trieu, Ly University Of Medicine And Pharmacy HCMC Vietnam Vo Xuan, Huy National Hospital of Tropical Diseases Vietnam Vongkhily, Aksone Vientiane Youth Centre for Health and Development Laos Vora, Tim HACC Cambodia Cambodia Wang, Qian National Center for Women and Children's Health, China CDC China Wang, Zixin The Chinese University of Hong Kong Hong Kong Wang, Yin Public Health Center of Chengdu China Wang, Fuxiang 4th Affiliated Hospital of Harbin Medical University China Wang, Xicheng AIDS Care Center of Yunnan Province China Wang, Wen Beijing STD and AIDS clinic diagnosis and treatment center China Wang, Kung-Ching Centers for Disease Control , R.O.C. Taiwan Wang, Hui Shenzhen 3rd People's Hospital China Wang, Chien-Chun Taipei City Hospital Taiwan Wangnan, CAO The Chinese University of Hong Kong Hong Kong Wansom, Tanyaporn USAMD-AFRIMS Thailand Weber, Shannon UCSF USA Wei, Hongxia The Second Hospital of Nanjing China Wei, Chunbo Beijing Ditan hospital China Wiboonchutikul, Surasak Bristol-Myers Squibb Thailand
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 38 LIST OF REGISTRANTS
Widhani, Alvina Faculty of Medicine, University of Indonesia Indonesia Wingate, John Simon Hong Kong Wirajaya, Putu I Udayana University Indonesia Wisaksana, Rudi Padjadjaran University, Faculty of Medicine Indonesia Wong, Ah Ping Society For AIDS Care Hong Kong Wong, Jack Tin Yu Abbvie Hong Kong Wong, Peng Shyan Penang Hospital Malaysia Wong, Pui Li Universiti Malaya Medical Centre Malaysia Wu, Angela Abbvie Hong Kong Wu, Hui Kai Abbvie Taiwan Taiwan Wu, Kuan-Sheng Kaohsiung Veterans General Hospital Taiwan Wu, Tak Chiu Queen Elizabeth Hospital Hong Kong Wynn Naing, Wynn Clinical care HIV/AIDS Myanmar Country Xin, Meiqi The Chinese University of Hong Kong Hong Kong Xu, Fujie Gilead Sciences Hong Kong Limited Hong Kong Yaemin, Natthakhet Chulalongkorn Hospital Thailand Yan, Yvonne Janssen Pharmaceutical Hong Kong Yang, Sang Youn Gilead Sciences Ltd South Korea Yang, Di Beijing Ditan hospital China Yang, Chia-Jui Far Eastern Memorial Hospital Taiwan Yang, Chien-Chang Taoyuan Chang Gung Memorial Hospital Taiwan Yashiro, Kumiko ViiV Healthcare Japan Yau, Yat-sun Queen Elizabeth Hospital Hong Kong Yau, Mabel Tung Wah College China Yeung, Sibia Pui Kwan Abbvie Hong Kong Yeung, Barry GSK Yi, Siyan KHANA Cambodia Yolanda, Anindia Udayana University Indonesia Yu, Po Chu Pansy Queen Elizabeth Hospital Hong Kong Yuan, Jinjin Infection Hospital of Fuzhou China Yuen, Pui Shan Karen Abbvie Hong Kong Yuen, Shuk Lai Gilead Sciences Hong Kong Yuen, Woon-Wah Hong Kong Infection Control Nurses' Association Hong Kong Yulidar, Yulidar Cipto Mangunkusumo General Hospital Indonesia Yunihastuti, Evy Faculty of Medicine, University of Indonesia Indonesia Zahid, Maria Dow University of Health Sciences Pakistan Zhang, YaQiong AbbVie China Zhang, Peng People's Hospital of Liuzhou China Zhang, Qiong-Fang The Second Affiliated Hospital of Chongqing M China Zhang, Yungui YunNan Aids Care Center China Zhao, Chuan Suining City Hospital of Infectious Diseases China Zheng, Tina GSK China China Zheng, Jingchan Chinese Association of STD and AIDS Prevention and Control China
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 39 LIST OF REGISTRANTS
Zhihua, Liu Institut Pasteur of Shanghai China Zhou, Ruifeng Public Health Center of Chengdu China Zhou, Ning Tianjin Centers for Disease Control and Prevention China Zolopa, Andrew ViiV Healthcare USA Zou, Wei 1st First Affiliated Hospital of Nanchang University China
Evaluation Report - The 1st Asia Pacific AIDS & Co-infections Conference 17 - 19 May 2016, Hong Kong 40 www.virology-education.com